Another study also supports that Osteopontin induces mesenchymal stem cells in the tumor microenvironment (TME) to differentiate into cancer-associated fibroblasts (CAFs), which promotes cancer development and can be stimulated to release periostin in the metastatic microenvironment [6,7]. Here, SPP1 is linked to cancer.